# Clinical Trial Evaluating the Safety and Efficacy of Tumor Thermosensitive Embolic Agent in Transcatheter Arterial Chemoembolization for Primary Liver Cancer

> **NCT07356531** · NA · RECRUITING · sponsor: **JIANGSU SHENMING Medical Technology CO., Ltd** · enrollment: 216 (estimated)

## Conditions studied

- Liver Cancer

## Interventions

- **DEVICE:** Transcatheter Arterial Chemoembolization

## Key facts

- **NCT ID:** NCT07356531
- **Lead sponsor:** JIANGSU SHENMING Medical Technology CO., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-07-29
- **Primary completion:** 2025-11-14
- **Final completion:** 2026-05-31
- **Target enrollment:** 216 (ESTIMATED)
- **Last updated:** 2026-01-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07356531

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07356531, "Clinical Trial Evaluating the Safety and Efficacy of Tumor Thermosensitive Embolic Agent in Transcatheter Arterial Chemoembolization for Primary Liver Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07356531. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*